![Kory Wentworth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kory Wentworth
Finansdirektör/CFO på
ENTRADA THERAPEUTICS, INC.
Förmögenhet: 744 709 $ per 2026-09-30
Profil
Kory James Wentworth is Chief Financial Officer & Treasurer at Entrada Therapeutics, Inc. since 2020.
Former positions include Treasurer & Vice President-Finance at Genetix Biotherapeutics, Inc. from 2017 to 2020, Executive Director & Corporate Controller at Alexion Pharmaceuticals, Inc. in 2017, and Audit Manager at PricewaterhouseCoopers LLP from 2002 to 2008.
Education includes undergraduate studies at Susquehanna University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-09-02 | 117 277 ( 0,3 % ) | 744 709 $ | 2026-09-30 |
Aktiva positioner av Kory Wentworth
| Företag | Position | Start |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Finansdirektör/CFO | 2020-11-01 |
Tidigare kända positioner av Kory Wentworth
| Företag | Position | Slut |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Comptroller/Controller/Revisor | 2020-09-08 |
| ALEXION PHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2017-12-01 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Comptroller/Controller/Revisor | 2008-12-01 |
Kory Wentworths utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
98
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Commercial Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Susquehanna University
 Susquehanna University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entrada Therapeutics, Inc.
 Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
